Early Completion of Model-Assisted Designs for Dose-Finding Trials Accurate assessment of a molecular classifier that guides patient care is of paramount importance in precision oncology. Recent years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback